OTC Markets OTCPK - Delayed Quote USD
Burzynski Research Institute, Inc. (BZYR)
At close: November 6 at 3:00 PM EST
Breakdown
TTM
2/29/2024
2/28/2023
2/28/2022
2/28/2021
Operating Expense
1,537.0920
1,335.4310
916.2920
976.6560
1,301.7710
Operating Income
-1,537.0920
-1,335.4310
-916.2920
-976.6560
-1,301.7710
Other Income Expense
--
--
--
--
97.7730
Pretax Income
-1,537.0920
-1,335.4310
-916.2920
-976.6560
-1,203.9980
Net Income Common Stockholders
-1,537.0920
-1,335.4310
-916.2920
-976.6560
-1,203.9980
Diluted NI Available to Com Stockholders
-1,537.0920
-1,335.4310
-916.2920
-976.6560
-1,203.9980
Basic EPS
-0.02
-0.01
-0.01
-0.01
-0.01
Diluted EPS
-0.02
-0.01
-0.01
-0.01
-0.01
Basic Average Shares
131,448.4440
131,448.4440
131,448.4440
131,448.4440
131,448.4440
Diluted Average Shares
131,448.4440
131,448.4440
131,448.4440
131,448.4440
131,448.4440
Total Operating Income as Reported
-1,537.0920
-1,335.4310
-916.2920
-976.6560
-1,301.7710
Total Expenses
1,537.0920
1,335.4310
916.2920
976.6560
1,301.7710
Net Income from Continuing & Discontinued Operation
-1,537.0920
-1,335.4310
-916.2920
-976.6560
-1,203.9980
Normalized Income
-1,537.0920
-1,335.4310
-916.2920
-976.6560
-1,203.9980
EBIT
-1,537.0920
-1,335.4310
-916.2920
-976.6560
-1,301.7710
EBITDA
-1,537.0920
-1,335.4310
-916.2920
-976.6560
-1,301.7710
Net Income from Continuing Operation Net Minority Interest
-1,537.0920
-1,335.4310
-916.2920
-976.6560
-1,203.9980
Normalized EBITDA
-1,537.0920
-1,335.4310
-916.2920
-976.6560
-1,301.7710
2/28/2021 - 1/2/1997
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
EFY.MU PharmaCyte Biotech Inc
22.50
0.00%
EAJF.F ValiRx plc
0.0135
-25.00%
CHNXF ChitogenX Inc.
0.0052
0.00%
GNFTF Genfit S.A.
5.55
0.00%
GLABF Gemina Laboratories Ltd.
0.3950
+16.55%
HOPHF Hemogenyx Pharmaceuticals Plc
0.0031
-92.25%
GSGTF GenSight Biologics S.A.
0.3200
0.00%
IVEVF Inventiva S.A.
3.6400
0.00%
MAAT.PA MaaT Pharma SA
7.66
+2.41%
INNMF Amplia Therapeutics Limited
0.0680
0.00%